Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Role of selenium in HIV infection.

Stone CA, Kawai K, Kupka R, Fawzi WW.

Nutr Rev. 2010 Nov;68(11):671-81. doi: 10.1111/j.1753-4887.2010.00337.x. Review.

2.

Selenium supplementation in HIV-infected patients: is there any potential clinical benefit?

Pitney CL, Royal M, Klebert M.

J Assoc Nurses AIDS Care. 2009 Jul-Aug;20(4):326-33. doi: 10.1016/j.jana.2009.03.006. Review.

PMID:
19576549
3.

Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy.

Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):169-73.

PMID:
11832687
4.

Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.

Kamwesiga J, Mutabazi V, Kayumba J, Tayari JC, Smyth R, Fay H, Umurerwa A, Baziruwiha M, Ntizimira C, Murebwayire A, Haguma JP, Nyiransabimana J, Habarurema D, Mukarukundo V, Nzabandora JB, Nzamwita P, Mukazayire E, Mills EJ, Seely D, McCready DJ, Warren D.

Trials. 2011 Aug 13;12:192. doi: 10.1186/1745-6215-12-192.

5.

Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.

Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2007 Jul;120(1):100-9.

PMID:
17606567
6.

Micronutrient supplementation in children and adults with HIV infection.

Irlam JH, Visser MM, Rollins NN, Siegfried N.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD003650. doi: 10.1002/14651858.CD003650.pub3. Review.

PMID:
21154354
7.

Selenium.

Alexander J.

Novartis Found Symp. 2007;282:143-9; discussion 149-53, 212-8. Review.

PMID:
17913229
8.

High risk of HIV-related mortality is associated with selenium deficiency.

Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):370-4.

PMID:
9342257
9.

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ.

AIDS. 2004 May 21;18(8):1169-77.

PMID:
15166532
11.

The role of selenium in chronic disease.

Boosalis MG.

Nutr Clin Pract. 2008 Apr-May;23(2):152-60. doi: 10.1177/0884533608314532. Review.

PMID:
18390782
12.
13.

Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.

Rossi M, Flepp M, Telenti A, Schiffer V, Egloff N, Bucher H, Vernazza P, Bernasconi E, Weber R, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Swiss Med Wkly. 2001 Aug 11;131(31-32):471-7.

14.

Effects of vitamins, including vitamin A, on HIV/AIDS patients.

Mehta S, Fawzi W.

Vitam Horm. 2007;75:355-83. Review.

PMID:
17368322
15.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
16.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.

AIDS. 2006 May 12;20(8):1171-9.

PMID:
16691069
17.

Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review.

Zeng L, Zhang L.

Trop Med Int Health. 2011 Dec;16(12):1474-82. doi: 10.1111/j.1365-3156.2011.02871.x. Epub 2011 Sep 7. Review.

18.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
19.

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB; Canadian Co-infection Cohort Study Investigators.

AIDS. 2010 Jul 31;24(12):1857-65. doi: 10.1097/QAD.0b013e32833adbb5.

PMID:
20479633
20.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
Items per page

Supplemental Content

Write to the Help Desk